Lung cancer: worldwide variation in occurrence and proportion attrib- utable to tobacco use. Lung Cancer 1993;9: 1-16.Parkin DM, Sasco AJ. Lung cancer: world-wide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 1993;9:1-16.lung cancer. J Int Assoc Study ...
One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Worldwide, the total number of people who are alive within 5 years of a cancer diagnosis, called the 5-year prevalence, is estimated to be ...
Lung cancer, disease characterized by uncontrolled growth of cells in the lungs. Lung cancer was first described in the mid-19th century. In the early 20th century it was considered relatively rare, but by the 21st century it had emerged as a leading cau
The prevalence of lung cancer in lung transplant recipients is low. Using accepted donor screening criteria, donor derived malignancy is exceptionally rare. While stage I disease is associated with improved survival in this cohort, survival is still not comparable to that of the general population, ...
[4]Melosky B, Kambartel K, Häntschel M, et al. Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis. Mol Diagn Ther. 2022 Jan;26(1):7-18. [5]Ding J, Ding X, Leng Z. Immunotherapy-based therapy as a promising treatment...
British Lung Foundation. What is Lung Cancer? Available at:https://www.blf.org.uk/support-for-you/lung-cancer/what-is-it. Last accessed March 2020. World Health Organization. Preventing Cancer. Available at:https://www.who.int/activities/preventing-cancer. Last accessed March 2020. ...
Lung cancer remains the leading cause of cancer deaths worldwide. Although low-dose spiral computed tomography (LDCT) screening is used for the detection of lung cancer in a high-risk population, false-positive results of LDCT remain a clinical problem. Here, we developed a blood test of a ...
has nominated IDE-251, a dual KAT6/7 inhibitor targeting 8p11 amplification tumors in breast and lung cancers, as a development candidate. IDE-251 is an equipotent, highly selective, small-molecule dual inhibitor of KAT6 and -7, both of which have been shown to support cancer cell ...
Lung cancer in individuals who have never smoked (LCINS) is estimated to be the fifth most common cause of cancer-related deaths worldwide in 2023, preferentially occurring in women and Asian populations. As smoking rates continue to decline, understanding the aetiology and features of this ...
Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312: 1604 – 1608 Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0.. IARC CancerBase No.5,...